High dietary
fructose is an important causative factor in the development of
metabolic syndrome-associated glomerular podocyte oxidative stress and injury. Here, we identified microRNA-377 (miR-377) as a
biomarker of oxidative stress in renal cortex of
fructose-fed rats, which correlated with podocyte injury and
albuminuria in
metabolic syndrome.
Fructose feeding increased miR-377 expression, decreased
superoxide dismutase (SOD) expression and activity, and caused O2(-) and H2O2 overproduction in kidney cortex or glomeruli of rats. This
reactive oxygen species induction increased
p38 MAPK phosphorylation and
thioredoxin-interacting
protein (TXNIP) expression and activated the
NOD-like receptor pyrin domain-containing 3 (NLRP3)
inflammasome to produce interleukin-1β in kidney glomeruli of
fructose-fed rats. These
pathological processes were further evaluated in cultured differentiated podocytes exposed to 5mM
fructose, or transfected with miR-377 mimic/inhibitor and TXNIP
siRNA, or co-incubated with
p38 MAPK inhibitor, demonstrating that miR-377 overexpression activates the O2(-)/
p38 MAPK/TXNIP/NLRP3
inflammasome pathway to promote oxidative stress and
inflammation in
fructose-induced podocyte injury.
Antioxidants pterostilbene and
allopurinol were found to ameliorate
fructose-induced
hyperuricemia, podocyte injury, and
albuminuria in rats. More importantly,
pterostilbene and
allopurinol inhibited podocyte miR-377 overexpression to increase SOD1 and SOD2 levels and suppress the O2(-)/
p38 MAPK/TXNIP/NLRP3
inflammasome pathway activation in vivo and in vitro, consistent with the reduction of oxidative stress and
inflammation. These findings suggest that miR-377 plays an important role in glomerular podocyte oxidative stress,
inflammation, and injury driven by high
fructose. Inhibition of miR-377 by
antioxidants may be a promising therapeutic strategy for the prevention of
metabolic syndrome-associated glomerular podocyte injury.